Joel Greenblatt’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Joel Greenblatt's ROIV Position: Q3 2026 in Review
Joel Greenblatt increased its Roivant Sciences (ROIV) stake by 13% in Q3 2026, buying an estimated $6.34M and bringing the position to 1,524,310 shares worth $55.7M. The position accounts for 0.11% of the portfolio, ranked #186.
Joel Greenblatt first reported a position in ROIV in Q2 2024 and has held it in 10 quarters since. 516 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Joel Greenblatt held 1,524,310 shares of Roivant Sciences worth $55.7M as of Q3 2026.
- Joel Greenblatt bought 174,845 Roivant Sciences shares in Q3 2026, an estimated $6.34M.
- Roivant Sciences made up 0.11% of Joel Greenblatt's portfolio in Q3 2026, its #186 holding.
- Joel Greenblatt first reported a position in Roivant Sciences in Q2 2024 and has held it in 10 quarters since.
- 516 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.